A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

L Scott, O Soepenberg, Jaap Verweij, Maja de Jonge, AST Planting, D McGovern, P Principe, R Obach, C Twelves

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)569-575
Number of pages7
JournalAnnals of Oncology
Issue number3
Publication statusPublished - 2007

Cite this